Completed PHASE3 NCT00000579

Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Lung Diseases Respiratory Distress Syndrome, Adult

Interventions Fluid Management Ketoconazole Low Tidal Volume Ventilation Lysofylline Methylprednisolone Positive End-Expiratory Pressure Pulmonary Artery Catheter

Updated 5 times since 2017 Last updated: Mar 22, 2016 Started: Sep 30, 1994 Completion: Jul 31, 2004

This PHASE3 trial investigates Lung Diseases and Respiratory Distress Syndrome, Adult and is currently completed. National Heart, Lung, and Blood Institute (NHLBI) leads this study, which shows 5 recorded versions since 1994 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Sep 1994

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Heart, Lung, and Blood Institute (NHLBI)

Data source: National Heart, Lung, and Blood Institute (NHLBI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ann Arbor, United States , Baltimore, United States , Boston, United States , Charlottesville, United States , Chicago, United States , Cleveland, United States , Denver, United States , Durham, United States , Houston, United States , Nashville, United States and 11 more locations